Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today reported its business update and consolidated financial results for the quarter ending March 31, 2026. "We have ...
MarketBeat on MSN
Innate Pharma Q1 earnings call highlights
Innate Pharma (NASDAQ:IPHA) said its first-quarter 2026 business update centered on three priority clinical assets: lacutamab ...
8hon MSN
Health care roundup: Market talk
Find insight on Roche Holding, AstraZeneca, Merck KGaA and more in the latest Market Talks covering the health care sector.
Bank of America Global Healthcare Conference 2026 May 13, 2026 1:40 PM EDTCompany ParticipantsJeffrey Poulton - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results